ReWind Therapeutics: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ReWind Therapeutics
Largest movements
- Cash -€321,853
down €321,853 (-20.3%), from €1.6m to €1.3m
mainly Current portion of long-term debt (-€6.8m) and Net result for the year (-€4.6m)
- Deferred charges and accrued income -€161,131
down €161,131 (-85.9%), from €187,688 to €26,557
- Tangible fixed assets -€143,175
down €143,175 (-77.5%), from €184,746 to €41,570
of which Plant, machinery and equipment: -€76,685
- Receivables within one year -€33,977
down €33,977 (-14.0%), from €243,170 to €209,192
of which Other amounts receivable: -€62,572
- Profit (loss) carried forward +€20.4m
up €20.4m (+79.2%), from -€25.7m to -€5.4m
- Contributions -€14.2m
down €14.2m (-83.7%), from €16.9m to €2.8m
- Current portion of long-term debt -€6.8m
down €6.8m (-62.8%), from €10.8m to €4.0m
- Trade debts -€323,997
down €323,997 (-51.2%), from €632,846 to €308,849
- Accrued charges and deferred income +€255,846
up €255,846 (+7,356%), from €3,478 to €259,324
- Staff costs -€473,820
down €473,820 (-43.5%), from €1.1m to €615,144
- Financial charges -€431,524
down €431,524 (-56.4%), from €764,883 to €333,359
- Gross operating margin -€407,721
down €407,721 (-338%), from -€120,541 to -€528,262
- Depreciation +€172,450
up €172,450 (+5.9%), from €2.9m to €3.1m
- Taxes +€103,366
up €103,366 (+93.2%), from -€110,964 to -€7,598
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,745,663 | €2,089,568 | -€656,096 | -23.9% |
| Fixed assets | 21/28 | €203,160 | €54,977 | -€148,183 | -72.9% |
| Intangible fixed assets | 21 | €6,888 | €1,880 | -€5,008 | -72.7% |
| Tangible fixed assets | 22/27 | €184,746 | €41,570 | -€143,175 | -77.5% |
| Plant, machinery and equipment | 23 | €109,286 | €32,601 | -€76,685 | -70.2% |
| Furniture and vehicles | 24 | €75,460 | €8,969 | -€66,490 | -88.1% |
| Financial fixed assets | 28 | €11,526 | €11,526 | = | 0.0% |
| Current assets | 29/58 | €2,542,503 | €2,034,590 | -€507,913 | -20.0% |
| Amounts receivable after more than one year | 29 | €524,118 | €533,167 | +€9,049 | +1.7% |
| Other amounts receivable | 291 | €524,118 | €533,167 | +€9,049 | +1.7% |
| Amounts receivable within one year | 40/41 | €243,170 | €209,192 | -€33,977 | -14.0% |
| Trade receivables | 40 | €4,324 | €32,919 | +€28,595 | +661% |
| Other amounts receivable | 41 | €238,846 | €176,274 | -€62,572 | -26.2% |
| Cash at bank and in hand | 54/58 | €1,587,527 | €1,265,674 | -€321,853 | -20.3% |
| Deferred charges and accrued income | 490/1 | €187,688 | €26,557 | -€161,131 | -85.9% |
| Total equity and liabilities | 10/49 | €2,745,663 | €2,089,568 | -€656,096 | -23.9% |
| Equity | 10/15 | -€8,770,450 | -€2,602,188 | +€6.2m | +70.3% |
| Contributions | 10/11 | €16,949,996 | €2,755,035 | -€14.2m | -83.7% |
| Capital | 10 | €16,949,996 | €2,755,035 | -€14.2m | -83.7% |
| Issued capital | 100 | €16,949,996 | €2,755,035 | -€14.2m | -83.7% |
| Profit (loss) carried forward | 14 | -€25,720,446 | -€5,357,223 | +€20.4m | +79.2% |
| Amounts payable | 17/49 | €11,516,113 | €4,691,756 | -€6.8m | -59.3% |
| Amounts payable within one year | 42/48 | €11,512,635 | €4,432,432 | -€7.1m | -61.5% |
| Current portion of amounts payable after more than one year | 42 | €10,750,493 | €4,000,000 | -€6.8m | -62.8% |
| Trade debts | 44 | €632,846 | €308,849 | -€323,997 | -51.2% |
| Suppliers | 440/4 | €632,846 | €308,849 | -€323,997 | -51.2% |
| Taxes, remuneration and social security | 45 | €129,296 | €123,583 | -€5,714 | -4.4% |
| Remuneration and social security | 454/9 | €129,296 | €123,583 | -€5,714 | -4.4% |
| Accrued charges and deferred income | 492/3 | €3,478 | €259,324 | +€255,846 | +7,356% |
| Non-recurring operating income | 76A | - | €1,598 | +€1,598 | |
| Remuneration, social security and pensions | 62 | €1,088,964 | €615,144 | -€473,820 | -43.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,898,569 | €3,071,019 | +€172,450 | +5.9% |
| Other operating charges | 640/8 | €1,053 | €1,440 | +€387 | +36.8% |
| Non-recurring operating charges | 66A | - | €99,657 | +€99,657 | |
| Gross operating margin | 9900 | -€120,541 | -€528,262 | -€407,721 | -338% |
| Operating profit (loss) | 9901 | -€4,109,127 | -€4,315,522 | -€206,395 | -5.0% |
| Financial income | 75/76B | €16,013 | €4,506 | -€11,507 | -71.9% |
| Recurring financial income | 75 | €16,013 | €4,506 | -€11,507 | -71.9% |
| Financial charges | 65/66B | €764,883 | €333,359 | -€431,524 | -56.4% |
| Recurring financial charges | 65 | €764,883 | €333,359 | -€431,524 | -56.4% |
| Profit (loss) for the period before taxes | 9903 | -€4,857,997 | -€4,644,375 | +€213,622 | +4.4% |
| Income taxes | 67/77 | -€110,964 | -€7,598 | +€103,366 | +93.2% |
| Profit (loss) for the period | 9904 | -€4,747,033 | -€4,636,777 | +€110,256 | +2.3% |
| Profit (loss) for the period to be appropriated | 9905 | -€4,747,033 | -€4,636,777 | +€110,256 | +2.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.